ArticleFrontiers in neurology2020

Exploiting Sphingo- and Glycerophospholipid Impairment to Select Effective Drugs and Biomarkers for CMT1A.

Davide Visigalli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.